Showing results (131-140 of 329) with videos related to

Sort By:
Pageof 33
American Heart Journal|June 1, 2002
Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromesRichard C Becker, Frederick A Spencer, Michael Gibson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 17, 2011
Rapidly regulating platelet activity in vivo with an antidote controlled platelet inhibitorShahid M Nimjee, Jens D Lohrmann, Haichen Wang, et al.
Iscience|January 3, 2023
Genetic ablation of diabetes-associated gene <i>Ccdc92</i> reduces obesity and insulin resistance in miceLu Ren, Wa Du, Dan Song, et al.
Thrombosis and Haemostasis|September 1, 2010
Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndromeRichard C Becker, John H Alexander, L Kristin Newby, et al.
Platelets|June 1, 2018
Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) studyWilliam A E Parker, Niclas Eriksson, Richard C Becker, et al.
Circulation. Cardiovascular Interventions|October 20, 2011
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summaryDavid P Faxon, John W Eikelboom, Peter B Berger, et al.
Journal of Medical Systems|May 28, 2010
Economic assessment of thrombocytopenia: CATCH RegistryEric L Eisenstein, Emily F Honeycutt, Kevin J Anstrom, et al.
Thrombosis and Haemostasis|October 12, 2012
Plasma proteomics of patients with non-valvular atrial fibrillation on chronic anti-coagulation with warfarin or a direct factor Xa inhibitorMark Y Chan, Min Lin, Joseph Lucas, et al.
European Heart Journal. Acute Cardiovascular Care|April 14, 2017
Direct factor IXa inhibition with the RNA-aptamer pegnivacogin reduces platelet reactivity in vitro and residual platelet aggregation in patients with acute coronary syndromesDawid L Staudacher, Vera Putz, Lukas Heger, et al.
Thrombosis and Haemostasis|July 26, 2011
Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspectiveDavid P Faxon, John W Eikelboom, Peter B Berger, et al.
Pageof 33